AMA, MGMA offer practice management guidance

The American Medical Association (AMA) and the Medical Group Management Association (MGMA) have developed an online directory of software vendors to help physicians gauge whether their practice management system (PMS) software is ICD-10-CM and HIPAA Version 5010-compliant.

With the upcoming transition to ICD-10-CM and the 5010 version of the HIPAA electronic standard transactions, coupled with the Medicare and Medicaid EHR incentive program, physician practices will be required to significantly upgrade or replace their current practice management system software.

The Practice Management System Software Directory provides vendor profiles, enabling physicians to choose the software that best fits their needs, the groups stated. The directory complements The Practice Management System Toolkit, also available from both organizations.

Physicians who use the directory have access to a roadmap to make it easier for practices to select and purchase the most appropriate PMS software. The information can be used to establish a practice’s organizational needs and take advantage of recent improvements in automation, according to the AMA and MGMA.

The Practice Management System Software Directory identifies the features most important to physician practices, including:

  • Price range for the product, excluding implementation costs,
  • Current installed customer base for the product,
  • Target market for the product,
  • Number of years the practice management software has been offered and
  • Any affiliated EHR products.
Click here to access the directory and toolkit.

 

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.